Registered entities
Merlion Pharmaceuticals Pte. Ltd.
Reg. No. 200202079ESingapore
Merlion Pharmaceuticals Gmbh
Reg. No. F1103_HRB112811BGermany
MerLion Pharmaceuticals GmbH
Reg. No. HRB112811Germany
Innovation
9 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy, Operations & transport; filing pace slowing. Cited 76 times.
| Year | Filings |
|---|---|
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Investor mix
25 investors on record; lead investors include Aravis, Denk Pharma.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 40% |
| Private equity | 3 | 12% |
| Other / undisclosed | 12 | 48% |